Skip to main content
. 2021 Jul 2;31(9):4045–4054. doi: 10.1007/s11695-021-05485-9

Table 5.

Linear regression predicting barriers to medication adherence in all samples (N = 501)

Dependent variable Adjusted R2 F R2 change Independent variables β [95% CI]
Barriers 0.05 3.181*** 0.07***
Women −0.062 [−7.226; 1.284]
Age 0.161** [0.121; 0.514]
Educational level −0.043 [−0.844; 0.296]
Unmarried 0.009 [−3.651; 4.435]
BMI −0.063 [−0.467; 0.079]
Obesity onset <15 −0.078 [−7.806; 0.854]
Medical comorbidities 0.078 [−0.573; 7.924]
Psychiatric disorder2 0.107* [0.879; 10.631]
BED diagnosis 0.028 [−4.503; 7.856]
BES total score 0.030 [−0.214; 0.362]
GSI-K9 0.069 [−1.440; 5.898]
TAS-20 total score 0.042 [−0.111; 0.256]

Note: * = p < 0.05; **= p < 0.01; DF: 112:488; 2Excluding binge eating disorder diagnosis

Abbreviation: BMI, body mass index; BES, Binge Eating Scale; GSI-9-K, global severity index of the Symptom Checklist-K-9; TAS-20, Toronto Alexithymia Scale